Ultragenyx Pharmaceutical (STU:UP0) Purchase Of Property, Plant, Equipment : €-20.7 Mil (TTM As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Ultragenyx Pharmaceutical Purchase Of Property, Plant, Equipment?

Ultragenyx Pharmaceutical's purchase of property, plant, equipment for the three months ended in Mar. 2024 was €-3.0 Mil. It means Ultragenyx Pharmaceutical spent €3.0 Mil on purchasing property, plant, equipment. Ultragenyx Pharmaceutical's purchase of property, plant, equipment for the trailing twelve months (TTM) ended in Mar. 2024 was €-20.7Mil.

Compared with last quarter (€-1.5 Mil in Dec. 2023 ), Ultragenyx Pharmaceutical spent more money on purchasing property, plant, equipment in Mar. 2024 (€-3.0 Mil).

Ultragenyx Pharmaceutical Purchase Of Property, Plant, Equipment Historical Data

The historical data trend for Ultragenyx Pharmaceutical's Purchase Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ultragenyx Pharmaceutical Purchase Of Property, Plant, Equipment Chart

Ultragenyx Pharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Purchase Of Property, Plant, Equipment

Get a 7-Day Free Trial

-22.35

-36.09

-64.69

-109.62

-40.59

Ultragenyx Pharmaceutical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Purchase Of Property, Plant, Equipment	Get a 7-Day Free Trial															-23.38	-12.87	-3.46	-1.47	-2.95

Ultragenyx Pharmaceutical Purchase Of Property, Plant, Equipment Calculation

The amount used to purchase PPE.

Purchase Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-20.7 Mil.

Ultragenyx Pharmaceutical Purchase Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Ultragenyx Pharmaceutical's Purchase Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.

Ultragenyx Pharmaceutical (STU:UP0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ultragenyx Pharmaceutical Inc (STU:UP0) » Definitions » Purchase Of Property, Plant, Equipment

Comparable Companies

Traded in Other Exchanges

RARE:USA RARE:Mexico

Address

60 Leveroni Court, Novato, CA, USA, 94949

Website

https://www.ultragenyx.com

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.

Ultragenyx Pharmaceutical (STU:UP0) Headlines

No Headlines